{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:02:01Z","timestamp":1784764921706,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20374"],"award-info":[{"award-number":["U22A20374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005045","name":"Ministry of Finance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.biopha.2024.117432","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T07:00:23Z","timestamp":1725865223000},"page":"117432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Application of galactosylated albumin for targeted delivery of triptolide to suppress hepatocellular carcinoma progression through inhibiting de novo lipogenesis"],"prefix":"10.1016","volume":"179","author":[{"given":"Liuchunyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0505-9666","authenticated-orcid":false,"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5601-9670","authenticated-orcid":false,"given":"Cheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3840-5292","authenticated-orcid":false,"given":"Yuanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117432_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.117432_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.114428","article-title":"Targeted therapy for hepatocellular carcinoma: challenges and opportunities","volume":"460","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.117432_bib3","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/cancers12061576","article-title":"Sorafenib resistance in hepatocellular carcinoma: the relevance of genetic heterogeneity","volume":"12","author":"Cabral","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.117432_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J. Anim. Physiol. Anim. Nutr."},{"key":"10.1016\/j.biopha.2024.117432_bib5","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.28508","article-title":"Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.117432_bib6","first-page":"65","article-title":"Tracing insights into de novo lipogenesis in liver and adipose tissues","author":"Wallace","year":"2020","journal-title":"Elsevier"},{"key":"10.1016\/j.biopha.2024.117432_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117432_bib8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.31392","article-title":"The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model","volume":"143","author":"Papaevangelou","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117432_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jhep.2008.07.036","article-title":"Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma","volume":"50","author":"Yamashita","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.117432_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1039\/D0NP00054J","article-title":"Triptolide: reflections on two decades of research and prospects for the future","volume":"38","author":"Tong","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biopha.2024.117432_bib11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1080\/10717544.2021.1983072","article-title":"Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy","volume":"28","author":"Zheng","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117432_bib12","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/ptr.6779","article-title":"Triptolide enhances lipolysis of adipocytes by enhancing ATGL transcription via upregulation of p53","volume":"34","author":"Wang","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2024.117432_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153739","article-title":"Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis","volume":"92","author":"Huang","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2024.117432_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2017.04.003","article-title":"Toxicity of triptolide and the molecular mechanisms involved","volume":"90","author":"Xi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.117432_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117432_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","article-title":"The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma","volume":"30","author":"Xu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117432_bib17","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/acsnano.9b01710","article-title":"Secreted protein acidic and rich in cysteine mediated biomimetic delivery of methotrexate by albumin-based nanomedicines for rheumatoid arthritis therapy","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2024.117432_bib18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1107\/S0907444912027047","article-title":"Structures of bovine, equine and leporine serum albumin","volume":"68","author":"Bujacz","year":"2012","journal-title":"Acta Crystallogr.\u00a0Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.biopha.2024.117432_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41467-017-00834-8","article-title":"Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.117432_bib20","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1021\/acs.molpharmaceut.5b00536","article-title":"Co-delivery of pirarubicin and paclitaxel by human serum albumin nanoparticles to enhance antitumor effect and reduce systemic toxicity in breast cancers","volume":"12","author":"Yi","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2024.117432_bib21","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.2147\/IJN.S184379","article-title":"Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration","author":"Huang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117432_bib22","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41401-018-0084-9","article-title":"Activation of natural killer T cells contributes to triptolide-induced liver injury in mice","volume":"39","author":"Wang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2024.117432_bib23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1021\/acs.chemrestox.0c00091","article-title":"Integrated proteomics and metabolomics reveal the mechanism of nephrotoxicity induced by triptolide","volume":"33","author":"Xie","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.biopha.2024.117432_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125719","article-title":"EGFR targeted albumin nanoparticles of oleanolic acid: in silico screening of nanocarrier, cytotoxicity and pharmacokinetics for lung cancer therapy","volume":"246","author":"Shukla","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.117432_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2024.117432_bib26","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkm882","article-title":"KEGG for linking genomes to life and the environment","volume":"36","author":"Kanehisa","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2024.117432_bib27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jhep.2011.08.022","article-title":"p53, a novel regulator of lipid metabolism pathways","volume":"56","author":"Goldstein","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.117432_bib28","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2024.117432_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature14557","article-title":"The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1","volume":"524","author":"Han","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117432_bib30","first-page":"2663","article-title":"Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo","author":"Zhang","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117432_bib31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cancers12061419","article-title":"Lipid metabolism in development and progression of hepatocellular carcinoma","volume":"12","author":"Sangineto","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.117432_bib32","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/cancers14071684","article-title":"Hypoalbuminemia is a hepatocellular carcinoma independent risk factor for tumor progression in low-risk bridge to transplant candidates","volume":"14","author":"N\u00fa\u00f1ez","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.117432_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/00387010.2018.1471092","article-title":"Investigation on the conformational changes of bovine serum albumin in a wide pH range from 2 to 12","volume":"51","author":"Chi","year":"2018","journal-title":"Spectrosc. Lett."},{"key":"10.1016\/j.biopha.2024.117432_bib34","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1021\/la062064e","article-title":"pH-dependent protein conformational changes in albumin: gold nanoparticle bioconjugates: a spectroscopic study","volume":"23","author":"Shang","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.biopha.2024.117432_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2024.117432_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101055","article-title":"Lipids in the tumor microenvironment: from cancer progression to treatment","volume":"80","author":"Corn","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biopha.2024.117432_bib37","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1158\/0008-5472.CAN-09-3871","article-title":"De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation","volume":"70","author":"Rysman","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.117432_bib38","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jcmm.16181","article-title":"Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma","volume":"25","author":"Huo","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2024.117432_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gutjnl-2017-315448","article-title":"\u03b2-catenin-activated hepatocellular carcinomas are addicted to fatty acids","volume":"68","author":"Senni","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2024.117432_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2024.117432_bib41","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.7150\/thno.34883","article-title":"Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:17:09Z","timestamp":1784762229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224013179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":41,"alternative-id":["S0753332224013179"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117432","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of galactosylated albumin for targeted delivery of triptolide to suppress hepatocellular carcinoma progression through inhibiting de novo lipogenesis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117432"}}